Previous close | 8.79 |
Open | 9.24 |
Bid | 8.81 x 400 |
Ask | 8.88 x 400 |
Day's range | 8.70 - 9.40 |
52-week range | 4.92 - 16.75 |
Volume | |
Avg. volume | 6,390,880 |
Market cap | 2.1B |
Beta (5Y monthly) | 0.75 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
In the closing of the recent trading day, Recursion Pharmaceuticals (RXRX) stood at $8.84, denoting a +0.57% change from the preceding trading day.
Zacks.com users have recently been watching Recursion Pharmaceuticals (RXRX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In this article, we will take a detailed look at the latest stocks Jim Cramer is recommending. If you want to skip our detailed analysis and see the top 5 stocks in this list, click Jim Cramer is Recommending These 5 Stocks Heading Into May 2024. Jim Cramer is concluding April by talking about some specific […]